hotspot -WSS

hotspot

author：comprehensive 2025-10-02 22:24:14 - browse：26595

Adam's take main illustration — Molly Ferguson/STAT

Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura Oncology’s “wall-crossing” stock sale.

Gilead needs Arcellx more than ever

The clinical trial setback for Trodelvy in non-small cell lung cancer reported by Gilead Sciences on Monday was another dose of bad news for the company’s oncology business. Strategically, does it make sense for Gilead to invest even more in antibody-drug conjugates like Trodelvy, where its lackluster profile and increased competition overall makes winning seem unlikely? Or, should Gilead double down on its Kite division and CAR-T cell therapy — the type of cancer treatments where it truly excels?

If the answers to those questions are no and yes (I lean that way), then Gilead’s current partnership with Arcellx, which is developing a BCMA-targeted CAR-T therapy for multiple myeloma, becomes a lot more important.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： NIH launches clinical trials and new research office for long Covid

focus

WSS

Free Covid tests will again be offered to all U.S. households

Information blocking fines are now fair game in health care

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Covid’s new normal has set in amid another rise in cases

What the airline industry can learn from medicine

Mitch McConnell episode has important public health takeaway

Wikipedia

hotspot

Gilead needs Arcellx more than ever

Wikipedia

Activists slam private health insurers over coverage restrictions

Pence says 'crackpot lawyers' told Trump what he wanted to hear

State Dept. review finds Biden bears some blame for Afghanistan failures

New safety details link Apellis eye drug to rare cases of blindness

BioMarin wins approval for gene therapy to treat hemophilia A

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Moonlake's readout produced a cash windfall. Risks remain

PBMs drew scrutiny in House hearing — and so did pharma

How one medical school became remarkably diverse

Scientists inch closer to single

knowledge

Grad students accuse University of California of wage theft

David Liu startup to focus on CRISPR delivery

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Scientists inch closer to single

Transgender sports debate: Physicians say bans are health issue

How the messy conversation about Dolly changed bioethics

knowledge

focus

focus

Wikipedia